Brief: Richter signs licence deal with Mithra Pharmaceuticals for new hormone therapy product

Richter Gedeon Vegyeszeti Gyar Nyrt

15/02/2023 06:43

Feb 15 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
 GDRB.BU  says in statement on Budapest bourse's website:
    * RICHTER AND MITHRA SIGN LICENCE AGREEMENT FOR SALE OF
DONESTA,
THE FIRST ESTETROL-BASED HORMONE THERAPY 
    * RICHTER SAYS AGREEMENT COVERS EUROPE, CIS COUNTRIES, LATIN
AMERICA, AUSTRALIA AND NEW ZEALAND -STATEMENT
    * UNDER THE DEAL MITHRA PHARMACEUTICALS IS ELIGIBLE TO
RECEIVE EUR
55 MILLION IN UPFRONT PAYMENT AND ADDITIONAL MILESTONE PAYMENTS
    * DONESTA IS A NOVEL PRODUCT CANDIDATE FOR THE TREATMENT OF
POST-MENOPAUSAL SYMPTOMS 
    * RICHTER WILL BE IN CHARGE OF SUPPLY AND PRODUCTION OF
PRODUCT
FOR ALL ITS TERRITORIES 

Source text for Eikon: [https://bse.hu/newkibdata/128845128/RCH230215ER01E.pdf
]
Further company coverage:  GDRB.BU 
 (Reporting by Krisztina  Than)
 ((Krisztina.Than@thomsonreuters.com;))